全文获取类型
收费全文 | 1719篇 |
免费 | 108篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 89篇 |
妇产科学 | 73篇 |
基础医学 | 246篇 |
口腔科学 | 39篇 |
临床医学 | 193篇 |
内科学 | 366篇 |
皮肤病学 | 29篇 |
神经病学 | 107篇 |
特种医学 | 185篇 |
外国民族医学 | 1篇 |
外科学 | 160篇 |
综合类 | 16篇 |
预防医学 | 126篇 |
眼科学 | 23篇 |
药学 | 123篇 |
中国医学 | 1篇 |
肿瘤学 | 63篇 |
出版年
2023年 | 6篇 |
2022年 | 12篇 |
2021年 | 30篇 |
2020年 | 18篇 |
2019年 | 41篇 |
2018年 | 34篇 |
2017年 | 34篇 |
2016年 | 22篇 |
2015年 | 35篇 |
2014年 | 39篇 |
2013年 | 64篇 |
2012年 | 67篇 |
2011年 | 68篇 |
2010年 | 63篇 |
2009年 | 69篇 |
2008年 | 89篇 |
2007年 | 84篇 |
2006年 | 75篇 |
2005年 | 67篇 |
2004年 | 46篇 |
2003年 | 58篇 |
2002年 | 61篇 |
2001年 | 45篇 |
2000年 | 44篇 |
1999年 | 40篇 |
1998年 | 58篇 |
1997年 | 58篇 |
1996年 | 54篇 |
1995年 | 49篇 |
1994年 | 47篇 |
1993年 | 31篇 |
1992年 | 22篇 |
1991年 | 30篇 |
1990年 | 22篇 |
1989年 | 44篇 |
1988年 | 31篇 |
1987年 | 27篇 |
1986年 | 23篇 |
1985年 | 18篇 |
1984年 | 18篇 |
1983年 | 10篇 |
1982年 | 16篇 |
1981年 | 12篇 |
1980年 | 10篇 |
1979年 | 11篇 |
1978年 | 10篇 |
1977年 | 15篇 |
1976年 | 10篇 |
1975年 | 5篇 |
1973年 | 4篇 |
排序方式: 共有1863条查询结果,搜索用时 15 毫秒
61.
Yu-Ling Chang Maura Rossetti David W. Gjertson Liudmilla Rubbi Michael Thompson Dennis J. Montoya Marco Morselli Felicia Ruffin Alexander Hoffmann Matteo Pellegrini Vance G. Fowler Jr Michael R. Yeaman Elaine F. Reed with the MRSA Systems Immunology Group 《Proceedings of the National Academy of Sciences of the United States of America》2021,118(10)
62.
G Poza J Montoya C Redondo J Ruiz N Vila J L Rodriguez-Tudela A Cerón E Simarro 《Clinical infectious diseases》2000,30(6):981-982
Meningitis caused by Pseudallescheria boydii is an uncommon infection of the CNS that usually has a poor prognosis and a difficult treatment. We describe a case of chronic meningitis caused by P. boydii in an immunocompetent host that was successfully treated with voriconazole, a new antifungal agent. 相似文献
63.
O'Malley CJ; Rasko JE; Basser RL; McGrath KM; Cebon J; Grigg AP; Hopkins W; Cohen B; O'Byrne J; Green MD; Fox RM; Berndt MC; Begley CG 《Blood》1996,88(9):3288-3298
This report describes the effect of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet production and platelet function in humans. Subjects with advanced solid tumors received PEG-rHuMGDF daily for up to 10 days. There was no increase in circulating platelet count at doses of 0.03 or 0.1 microgram/kg/d by day 12 of study. At doses of 0.3 and 1.0 microgram/kg/d there was a threefold median increase (maximum 10-fold) in platelet count by day 16. The platelets produced in vivo in response to PEG-rHuMGDF showed unchanged aggregation and adenosine triphosphate (ATP)-release responses in in vitro assays. Tests included aggregation and release of ATP in response to adenosine diphosphate (ADP) (10, 5, 2.5, and 1.25 mumol/L), collagen (2 micrograms/mL), thrombin-receptor agonist peptide (TRAP, 10 mumol/L) and ristocetin (1.5 mg/mL). Administration of aspirin to an individual with platelet count of 1,771 x 10(3)/L resulted in the typical aspirin-induced ablation of the normal aggregation and ATP-release response to stimulation with arachidonic acid (0.5 mg/mL), collagen, and ADP (2.5 and 1.25 mumol/L). There was no change in the expression of the platelet-surface activation marker CD62P (P-selectin) nor induction of the fibrinogen binding site on glycoprotein IIb/IIIa as reported by the monoclonal antibody, D3GP3. An elevation of reticulated platelets was evident after 3 days of treatment with PEG-rHuMGDF and preceded the increase in circulating platelet count by 5 to 8 days; this reflected the production of new platelets in response to PEG-rHuMGDF. At later time points, the mean platelet volume (MPV) decreased in a manner inversely proportional to the platelet count. Levels of plasma glycocalicin, a measure of platelet turnover, rose 3 days after the initial increase in the peripheral platelet count. The level of plasma glycocalicin was proportional to the total platelet mass, suggesting that platelets generated in response to PEG-rHuMGDF were not more actively destroyed. Thus, the administration of PEG-rHuMGDF, to humans, increased the circulating platelet count and resulted in fully functional platelets, which showed no detectable increase in reactivity nor alteration in activation status. 相似文献
64.
65.
Pope Caitlin N. Montoya Jessica L. Vasquez Elizabeth Pérez-Santiago Josué Ellis Ronald McCutchan J. Allen Jeste Dilip V. Moore David J. Marquine María J. 《Journal of neurovirology》2020,26(6):888-898
Journal of NeuroVirology - Metabolic syndrome (MetS), a constellation of related metabolic risk factors, is a common comorbidity associated with cognitive difficulty in people living with HIV... 相似文献
66.
Tessa Timmers Rik Ossenkoppele Denise Visser Hayel Tuncel Emma E Wolters Sander CJ Verfaillie Wiesje M van der Flier Ronald Boellaard Sandeep SV Golla Bart NM van Berckel 《Journal of cerebral blood flow and metabolism》2020,40(12):2464
The aim of this study was to investigate the test–retest (TRT) repeatability of various parametric quantification methods for [18F]Flortaucipir positron emission tomography (PET). We included eight subjects with dementia or mild cognitive impairment due to Alzheimer’s disease and six cognitively normal subjects. All underwent two 130-min dynamic [18F]Flortaucipir PET scans within 3 ± 1 weeks. Data were analyzed using reference region models receptor parametric mapping (RPM), simplified reference tissue method 2 (SRTM2) and reference logan (RLogan), as well as standardized uptake value ratios (SUVr, time intervals 40–60, 80–100 and 110–130 min post-injection) with cerebellar gray matter as reference region. We obtained distribution volume ratio or SUVr, first for all brain regions and then in three tau-specific regions-of-interest (ROIs). TRT repeatability (%) was defined as |retest–test|/(average (test + retest)) × 100. For all methods and across ROIs, TRT repeatability ranged from (median (IQR)) 0.84% (0.68–2.15) to 6.84% (2.99–11.50). TRT repeatability was good for all reference methods used, although semi-quantitative models (i.e. SUVr) performed marginally worse than quantitative models, for instance TRT repeatability of RPM: 1.98% (0.78–3.58) vs. SUVr80–100: 3.05% (1.28–5.52), p < 0.001. Furthermore, for SUVr80–100 and SUVr110–130, with higher average SUVr, more variation was observed. In conclusion, while TRT repeatability was good for all models used, quantitative methods performed slightly better than semi-quantitative methods. 相似文献
67.
68.
69.
Elevated numbers of primitive Philadelphia chromosome-positive (Ph+) progenitors, including long-term culture-initiating cells (LTC-IC) as well as colony-forming cells (CFC), have been previously described in the blood of patients with chronic myeloid leukemia (CML) in chronic phase with high white blood cell counts. In the present study, which focused primarily on an analysis of circulating progenitors present in such patients at diagnosis, we discovered the frequent and occasionally exclusive presence of circulating normal (Ph-) LTC-IC, often at levels above those seen for LTC-IC in the blood of normal individuals. The presence of detectable numbers of circulating Ph- LTC-IC was independent of the fact that the same peripheral blood samples also contained elevated numbers of predominantly or exclusively Ph+ CFC. Interestingly, both the Ph+ and Ph- LTC-IC in these samples were CD34+CD71- and variably CD38- and Thy-1+, as previously documented for LTC-IC in normal marrow. Thus, neither CD38 nor Thy-1 expression was useful for discriminating between Ph+ and Ph- LTC-IC in mixed populations. Nevertheless, an association of these phenotypes with LTC- IC function did allow highly enriched (> 5% pure) suspensions of either Ph+ or Ph- LTC-IC to be obtained from selected samples of CML blood in which the initial LTC-IC population was either predominantly Ph+ or Ph- , respectively. These findings suggest that the mechanisms causing mobilization of leukemic stem cells in untreated CML patients may affect their normal counterparts. They also indicate a possible new source of autologous cells for the support of intensive therapy of CML patients. Finally, they provide a method for obtaining the most highly purified populations of Ph+ LTC-IC described to date. This method should be useful for further analyses of the molecular activities of these very primitive neoplastic cells. 相似文献
70.
A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy 下载免费PDF全文
Nelma Pertega‐Gomes Sergio Felisbino Charlie E Massie Jose R Vizcaino Ricardo Coelho Chiranjeevi Sandi Susana Simoes‐Sousa Sarah Jurmeister Antonio Ramos‐Montoya Mohammad Asim Maxine Tran Elsa Oliveira Alexandre Lobo da Cunha Valdemar Maximo Fatima Baltazar David E Neal Lee GD Fryer 《The Journal of pathology》2015,236(4):517-530
Metabolic adaptation is considered an emerging hallmark of cancer, whereby cancer cells exhibit high rates of glucose consumption with consequent lactate production. To ensure rapid efflux of lactate, most cancer cells express high levels of monocarboxylate transporters (MCTs), which therefore may constitute suitable therapeutic targets. The impact of MCT inhibition, along with the clinical impact of altered cellular metabolism during prostate cancer (PCa) initiation and progression, has not been described. Using a large cohort of human prostate tissues of different grades, in silico data, in vitro and ex vivo studies, we demonstrate the metabolic heterogeneity of PCa and its clinical relevance. We show an increased glycolytic phenotype in advanced stages of PCa and its correlation with poor prognosis. Finally, we present evidence supporting MCTs as suitable targets in PCa, affecting not only cancer cell proliferation and survival but also the expression of a number of hypoxia‐inducible factor target genes associated with poor prognosis. Herein, we suggest that patients with highly glycolytic tumours have poorer outcome, supporting the notion of targeting glycolytic tumour cells in prostate cancer through the use of MCT inhibitors. © 2015 Authors. Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland. 相似文献